State of Tennessee, Department of Treasury’s TG Therapeutics TGTX Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.85M	Sell	51,926 -1,936	-4%	-$79.2K	0.01%	796
2026 Q1	$1.79M	Buy	53,862 +239	+0.4%	+$7.12K	0.01%	982
2025 Q4	$1.58M	Sell	53,623 -5,198	-9%	-$170K	0.01%	1028
2025 Q3	$2.12M	Buy	58,821 +493	+0.8%	+$16.2K	0.01%	891
2025 Q2	$2.1M	Sell	58,328 -860	-1%	-$32K	0.01%	876
2025 Q1	$2.33M	Sell	59,188 -695	-1%	-$23.4K	0.01%	802
2024 Q4	$1.8M	Buy	59,883 +13,228	+28%	+$380K	0.01%	960
2024 Q3	$1.09M	Buy	+46,655	New	+$1.02M	﹤0.01%	1175

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

State of Tennessee, Department of Treasury's TGTX Position: Q2 2026 in Review

State of Tennessee, Department of Treasury reduced its TG Therapeutics (TGTX) stake by 3.6% in Q2 2026, selling an estimated $79.2K and leaving 51,926 shares worth $2.85M. The position accounts for 0.01% of the portfolio, ranked #796.

State of Tennessee, Department of Treasury first reported a position in TGTX in Q3 2024 and has held it in 8 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

State of Tennessee, Department of Treasury held 51,926 shares of TG Therapeutics worth $2.85M as of Q2 2026.
State of Tennessee, Department of Treasury sold 1,936 TG Therapeutics shares in Q2 2026, an estimated $79.2K.
TG Therapeutics made up 0.01% of State of Tennessee, Department of Treasury's portfolio in Q2 2026, its #796 holding.
State of Tennessee, Department of Treasury first reported a position in TG Therapeutics in Q3 2024 and has held it in 8 quarters since.
427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on State of Tennessee, Department of Treasury's 13F filing for Q2 2026, filed 14 Aug 2026.